Technology area: Biotechnology & Pharmaceuticals
2 pending office actions • 1 art units • 1 examiners • 0 of 2 (0%) have an AI response strategy ready
Spago Nanomedical AB has 2 pending office actions in Biotechnology & Pharmaceuticals. The matters are concentrated with 1 distinct examiner and 1 distinct art unit, indicating a focused prosecution path rather than distribution across multiple examination groups.
LEWOCZKO, EVAN MICHAEL is the busiest examiner, with responsibility for 2 pending matters. Counsel can therefore direct procedural monitoring and response strategy toward a single examiner relationship and art-unit context.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Double-patenting + other | 2 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| LEWOCZKO, EVAN MICHAEL | 2 | — | — |
| Art Unit | Apps |
|---|---|
| 1612 | 2 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18844712 | GLOBULAR NANOSTRUCTURES HAVING AN ANCHORING LAYER | LEWOCZKO, EVAN MICHAEL | 1612 | §103§112DP | Non-Final OA | — | Pending | Sep 06, 2024 |
| 18844721 | GLOBULAR NANOSTRUCTURES | LEWOCZKO, EVAN MICHAEL | 1612 | §103§112DP | Non-Final OA | — | Pending | Sep 06, 2024 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialSpago Nanomedical AB has 2 pending office actions as of October 2026, spread across 1 art units and 1 examiners.
Evan Michael Lewoczko has the most, with 2 of Spago Nanomedical AB's pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
